Effects of Endocrine Interventions Targeting ERα or PR on Breast Cancer Risk in the General Population and Carriers of BRCA1/2 Pathogenic Variants.

MLA

Huber, Deborah, et al. “Effects of Endocrine Interventions Targeting ERα or PR on Breast Cancer Risk in the General Population and Carriers of BRCA1/2 Pathogenic Variants.” International Journal of Molecular Sciences, vol. 25, no. 11, June 2024, p. 5894. EBSCOhost, https://doi.org/10.3390/ijms25115894.

APA

Huber, D., Hatzipanagiotou, M., Schüler-Toprak, S., Ortmann, O., & Treeck, O. (2024). Effects of Endocrine Interventions Targeting ERα or PR on Breast Cancer Risk in the General Population and Carriers of BRCA1/2 Pathogenic Variants. International Journal of Molecular Sciences, 25(11), 5894. https://doi.org/10.3390/ijms25115894

Chicago

Huber, Deborah, Maria Hatzipanagiotou, Susanne Schüler-Toprak, Olaf Ortmann, and Oliver Treeck. 2024. “Effects of Endocrine Interventions Targeting ERα or PR on Breast Cancer Risk in the General Population and Carriers of BRCA1/2 Pathogenic Variants.” International Journal of Molecular Sciences 25 (11): 5894. doi:10.3390/ijms25115894.